The favorable prognosis of POLE-mutant and dMMR subtypes has been suggested to correlate with increased density of CD8+ tumor-infiltrating lymphocytes (TILs) and higher PD-1expression [8,9]. This evidence concerns the gene CD8A and neoplasm.